Page last updated: 2024-08-25

zoledronic acid and Epstein-Barr Virus Infections

zoledronic acid has been researched along with Epstein-Barr Virus Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altvater, B; Bisping, G; Bollard, CM; Hansmeier, A; Juergens, H; Landmeier, S; Moosmann, A; Pscherer, S; Rossig, C; Varnholt, L1

Other Studies

1 other study(ies) available for zoledronic acid and Epstein-Barr Virus Infections

ArticleYear
Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer.
    Journal of immunotherapy (Hagerstown, Md. : 1997), 2009, Volume: 32, Issue:3

    Topics: Antigen-Presenting Cells; Antigens, Viral; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Diphosphonates; Epitopes; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Imidazoles; Immunotherapy; Receptors, Antigen, T-Cell, gamma-delta; Transduction, Genetic; Tumor Necrosis Factor-alpha; Zoledronic Acid

2009